Connection

SILVANA DE CASTRO FARIA to Fluorodeoxyglucose F18

This is a "connection" page, showing publications SILVANA DE CASTRO FARIA has written about Fluorodeoxyglucose F18.
  1. FDG-PET Assessment of Other Gynecologic Cancers. PET Clin. 2018 Apr; 13(2):203-223.
    View in: PubMed
    Score: 0.402
  2. [18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer. PET Clin. 2018 Apr; 13(2):165-177.
    View in: PubMed
    Score: 0.099
  3. FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics. 2005 Jan-Feb; 25(1):191-207.
    View in: PubMed
    Score: 0.040
  4. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol. 2004 Dec; 183(6):1619-28.
    View in: PubMed
    Score: 0.020
  5. Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma. Ann Nucl Med. 2008 Feb; 22(2):111-4.
    View in: PubMed
    Score: 0.013
  6. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007 May 01; 25(13):1753-9.
    View in: PubMed
    Score: 0.012
  7. Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. World J Gastroenterol. 2005 Dec 14; 11(46):7284-9.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.